Author

M. van Tuil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:organoid / primary culture· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Janse· 2 shared J. Drost· 2 shared J. Y. Hehir-Kwa· 2 shared P. Kemmeren· 2 shared A. Groenendijk· 1 shared B. B. J. Tops· 1 shared B. B. Tops· 1 shared C. Calandrini· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Janse

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular characterization reveals subclasses of 1q gain in intermediate-risk Wilms tumors

I. A. van Belzen, M. van Tuil, S. Badloe, E. Strengman, A. Janse, E. T. Verwiel, D. F. van der Leest, S. de Vos, J. L. Baker-Hernandez, A. Groenendijk, R. de Krijger, H. H. Kerstens, J. Drost, M. M. van den Heuvel-Eibrink, B. B. Tops, , J. Y. Hehir-Kwa

The paper identifies subclasses of 1q gain in Wilms tumors by integrating genomic and expression data, revealing differences in mutational mechanisms and functional effects.

bioRxiv · Aug 12, 2022 · PreprintCancer Biology

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

M. T. Meister, M. J. A. Groot Koerkamp, T. de Souza, W. B. Breunis, E. Frazer-Mendelewska, M. Brok, J. DeMartino, F. Manders, C. Calandrini, H. H. D. Kerstens, A. Janse, M. E. M. Dolman, S. Eising, K. P. S. Langenberg, M. van Tuil, , F. C. P. Holstege

This study generates tumor organoid models of rhabdomyosarcoma subtypes that closely resemble original tumors and can be used for drug screening and genetic modification.

bioRxiv · Jan 3, 2022Cancer Biology